Paola Dal Cin

Paola Dal Cin

Harvard University

H-index: 99

North America-United States

About Paola Dal Cin

Paola Dal Cin, With an exceptional h-index of 99 and a recent h-index of 50 (since 2020), a distinguished researcher at Harvard University, specializes in the field of genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Optimization of advanced molecular genetic testing utilization in hematopathology: A goldilocks approach to bone marrow testing

Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion Genes

Molecular Pathology of Soft Tissue and Bone Tumors

Characteristic nuclear membrane ALK reactivity in chronic myelomonocytic leukemia with RANBP2‐ALK fusion

TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence

NR4A3 expression is consistently absent in acinic cell carcinomas of the breast: a potential nosologic shift

TP63 fusions drive enhancer rewiring, lymphomagenesis, and dependence on EZH2

Inflammatory and nested testicular sex cord tumor: a novel neoplasm with aggressive clinical behavior and frequent EWSR1:: ATF1 gene fusions

Paola Dal Cin Information

University

Position

Harvard medical school

Citations(all)

36230

Citations(since 2020)

9842

Cited By

28717

hIndex(all)

99

hIndex(since 2020)

50

i10Index(all)

360

i10Index(since 2020)

161

Email

University Profile Page

Google Scholar

Paola Dal Cin Skills & Research Interests

genetics

Top articles of Paola Dal Cin

Title

Journal

Author(s)

Publication Date

Optimization of advanced molecular genetic testing utilization in hematopathology: A goldilocks approach to bone marrow testing

JCO Oncology Practice

Ali AlJabban

Henry Paik

Jon C Aster

Nancy Berliner

Jennifer Brouillard

...

2024/2

Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion Genes

The American Journal of Surgical Pathology

David L Kolin

Marisa R Nucci

Gulisa Turashvili

Sharon J Song

Sophie Corbett-Burns

...

2024/1/1

Molecular Pathology of Soft Tissue and Bone Tumors

Adrian Marino-Enriquez

Alanna J Church

Neal I Lindeman

Paola Dal Cin

2023/11/1

Characteristic nuclear membrane ALK reactivity in chronic myelomonocytic leukemia with RANBP2‐ALK fusion

American Journal of Hematology

Christopher B Hergott

Paola Dal Cin

Jason L Hornick

Eric S Winer

Ruben D Carrasco

...

2023/2

TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence

Science translational medicine

Gongwei Wu

Noriaki Yoshida

Jihe Liu

Xiaoyang Zhang

Yuan Xiong

...

2023/9/20

NR4A3 expression is consistently absent in acinic cell carcinomas of the breast: a potential nosologic shift

Modern Pathology

Edward T Richardson

Pier Selenica

Fresia Pareja

Paola Dal Cin

Etta Hanlon

...

2023/6/1

TP63 fusions drive enhancer rewiring, lymphomagenesis, and dependence on EZH2

Cancer Research

Gongwei Wu

Noriaki Yoshida

Jihe Liu

Xiaoyang Zhang

Yuan Xiong

...

2023/4/4

Inflammatory and nested testicular sex cord tumor: a novel neoplasm with aggressive clinical behavior and frequent EWSR1:: ATF1 gene fusions

The American Journal of Surgical Pathology

Andres M Acosta

Julia A Bridge

Paola S Dal Cin

Lynette M Sholl

Kristine M Cornejo

...

2023/4/1

t (4; 12)(q12; p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity

Blood Advances

Sarah B Mueller

Paola Dal Cin

Long P Le

Dora Dias-Santagata

Jochen K Lennerz

...

2022/1/8

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

Blood advances

Olga K Weinberg

Alexa Siddon

Yazan F Madanat

Jeffrey Gagan

Daniel A Arber

...

2022/5/10

9. ETV6-PDGFRA fusions detected by FISH in acute myeloid leukemia with translocation t (4; 12)(q12; p13) are false-positive

Cancer Genetics

Sarah Mueller

Paola Dal Cin

Long Le

Dora Dias-Santagata

Jochen Lennerz

...

2022/1/1

Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional …

Modern Pathology

Rashmi Kanagal-Shamanna

Attilio Orazi

Robert P Hasserjian

Daniel A Arber

Kaaren Reichard

...

2022/5

NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype

Leukemia Research

Maximiliano Ramia de Cap

Leo P Wu

German A Pihan

Damodaran Narayanan

Elizabeth A Morgan

...

2022/12/1

Atypical uterine polyps show morphologic and molecular overlap with mullerian adenosarcoma but follow a benign clinical course

Modern Pathology

David B Chapel

Brooke E Howitt

Lynette M Sholl

Paola Dal Cin

Marisa R Nucci

2022/1/1

Guiding the global evolution of cytogenetic testing for hematologic malignancies

Blood, The Journal of the American Society of Hematology

Yassmine MN Akkari

Linda B Baughn

Adrian M Dubuc

Adam C Smith

Mar Mallo

...

2022/4/14

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Blood, The Journal of the American Society of Hematology

Daniel A Arber

Attilio Orazi

Robert P Hasserjian

Michael J Borowitz

Katherine R Calvo

...

2022/9/15

Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative …

Modern Pathology

Rashmi Kanagal-Shamanna

Attilio Orazi

Robert P Hasserjian

Daniel A Arber

Kaaren Reichard

...

2022/4/1

Low-grade fibromyxoid sarcoma of the vulva and vagina: clinical, pathologic, and molecular characterization of 7 cases and review of the literature

Danielle Costigan

Paola Dal Cin

Christopher DM Fletcher

Marisa R Nucci

Carlos Parra-Herran

...

2022/9/1

Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy

The oncologist

Valentina Nardi

Steven L McAfee

Paola Dal Cin

Harrison K Tsai

Philip C Amrein

...

2022/2/1

N‐terminus DUX4‐immunohistochemistry is a reliable methodology for the diagnosis of DUX4‐fused B‐lymphoblastic leukemia/lymphoma (N‐terminus DUX4 IHC …

Genes, Chromosomes and Cancer

Bradford J Siegele

Anat O Stemmer‐Rachamimov

Henrik Lilljebjorn

Thoas Fioretos

Amanda C Winters

...

2022/8

See List of Professors in Paola Dal Cin University(Harvard University)

Co-Authors

academic-engine